Literature DB >> 24202616

Lack association of body mass index with disease activity composites of rheumatoid arthritis in Korean population: cross-sectional observation.

Jung-Yoon Choe1, Jisuk Bae, Hwajeong Lee, Sung-Hoon Park, Seong-Kyu Kim.   

Abstract

The debate regarding the influence of body mass index (BMI) on clinical disease activity in rheumatoid arthritis (RA) remains unsolved. This study investigates whether BMI is associated with disease activity composites and clinical parameters in Korean patients with RA. A total of 568 patients with RA were consecutively enrolled in this study. BMI and disease activity composites including the Disease Activity Score 28 (DAS28) and the Clinical/Simplified Disease Activity Index (CDAI/SDAI) were assessed. Statistical analyses were performed using Chi-square, one-way ANOVA, and multivariate regression analyses. Remission of RA disease activity was defined as ≤2.6 in a DAS28 score. The mean BMI was 22.3 kg/m(2) (SD 3.1). About 60.6 % (n = 344) of enrolled patients fell into the underweight and normal BMI categories. Swollen joint count was significantly different among the four BMI categories (p = 0.038). Multivariate regression analysis showed a negative correlation of BMI and erythrocyte sediment rate (ESR) in all patients (β= - 0.011, p = 0.049) and also found that other disease activity indices were not found to be associated with BMI. In patients with remission, lower BMI was associated with higher physician global estimate (β= - 0.446, p = 0.030). The negative association between BMI and ESR in the non-remission group was noted (β= - 0.016, p = 0.019). This study revealed lack association between BMI and disease activity composites of RA, although only ESR was found to be associated with BMI in RA patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24202616     DOI: 10.1007/s10067-013-2427-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

1.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

2.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Authors:  D Jawaheer; J Olsen; M Lahiff; S Forsberg; J Lähteenmäki; I G da Silveira; F A Rocha; I M Magalhães Laurindo; L M Henrique da Mota; A A Drosos; E Murphy; C Sheehy; E Quirke; M Cutolo; S Rexhepi; J Dadoniene; S M M Verstappen; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

4.  Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.

Authors:  Aharna Guin; Maitrayee Chatterjee Adhikari; Sumit Chakraborty; Pradyot Sinhamahapatra; Alakendu Ghosh
Journal:  Semin Arthritis Rheum       Date:  2013-02-12       Impact factor: 5.532

5.  Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation.

Authors:  D A Fraser; J Thoen; J E Reseland; O Førre; J Kjeldsen-Kragh
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

6.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Authors:  J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

7.  Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.

Authors:  Veronica Sanna; Antonio Di Giacomo; Antonio La Cava; Robert I Lechler; Silvia Fontana; Serafino Zappacosta; Giuseppe Matarese
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Redefining overweight and obesity in rheumatoid arthritis patients.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Yiannis Koutedakis; Alan M Nevill; Karen M Douglas; Athanasios Jamurtas; Jet J C S Veldhuijzen van Zanten; Mourad Labib; George D Kitas
Journal:  Ann Rheum Dis       Date:  2007-02-08       Impact factor: 19.103

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

View more
  6 in total

1.  A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases.

Authors:  Yi Xuan Lee; Yu Heng Kwan; Ka Keat Lim; Chuen Seng Tan; Nai Lee Lui; Jie Kie Phang; Eng Hui Chew; Truls Ostbye; Julian Thumboo; Warren Fong
Journal:  Singapore Med J       Date:  2019-06       Impact factor: 1.858

2.  Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy.

Authors:  Kenji Yamazaki; Etsuji Suzuki; Ryuhei Ishihara; Toshiaki Miyamoto
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

Review 3.  Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response.

Authors:  Claire I Daïen; Jérémie Sellam
Journal:  RMD Open       Date:  2015-06-29

Review 4.  Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Authors:  Roberta Lupoli; Paolo Pizzicato; Antonella Scalera; Pasquale Ambrosino; Manuela Amato; Rosario Peluso; Matteo Nicola Dario Di Minno
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156

5.  Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study.

Authors:  Jian-Zi Lin; Jin-Jian Liang; Jian-Da Ma; Qian-Hua Li; Ying-Qian Mo; Wan-Mei Cheng; Xiao-Ling He; Nan Li; Ming-Hui Cao; Dan Xu; Lie Dai
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-30       Impact factor: 12.910

6.  Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.

Authors:  Iván Arias de la Rosa; Alejandro Escudero-Contreras; Miriam Ruiz-Ponce; Cristóbal Román-Rodríguez; Carlos Pérez-Sánchez; María Del Carmen Ábalos-Aguilera; Rafaela Ortega-Castro; Juan Alcaide; Mora Murri; Pilar Font; Jerusalem Calvo-Gutiérrez; Maria Luque-Tevar; Alejandra Maria Patiño-Trives; Rocío Guzmán-Ruiz; Maria Del Mar Malagón; Francisco José Tinahones; Eduardo Collantes-Estévez; Chary López-Pedrera; Nuria Barbarroja
Journal:  Front Immunol       Date:  2021-10-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.